| |
| |
|
| Insider
Information: |
Harper Philip R |
| Relationship: |
10% Owner |
| City: |
Bethesda |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
4,959,819 |
|
|
Indirect Shares
|
220,000 |
|
|
| Direct
Value |
$917,567 |
|
|
|
Indirect Value
|
$40,700 |
|
|
| Total
Shares |
5,179,819 |
|
|
| Total
Value |
$958,267 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
American Capital Ltd |
ACAS |
Director |
2017-01-03 |
0 |
2017-01-03 |
0 |
Premium* |
|
|
Aevi Genomic Medicine Inc |
GNMX |
10% Owner |
2017-09-01 |
4,959,819 |
2017-09-01 |
220,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GNMX |
Aevi Genomic Medicine Inc |
10% Owner |
– – • |
2017-09-01 |
4 |
B |
$1.20 |
$100,530 |
D/D |
83,775 |
4,959,819 |
2.45 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
10% Owner |
– – • |
2017-08-23 |
4 |
B |
$1.20 |
$6,840 |
D/D |
5,700 |
4,876,044 |
2.37 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
10% Owner |
– – • |
2017-08-22 |
4 |
B |
$1.20 |
$5,593 |
D/D |
4,661 |
4,870,344 |
2.37 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
10% Owner |
– – • |
2017-08-10 |
4 |
B |
$1.19 |
$24,359 |
D/D |
20,470 |
4,865,683 |
2.37 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
10% Owner |
– – • |
2017-03-24 |
4 |
B |
$1.60 |
$86,122 |
D/D |
53,826 |
4,845,213 |
2.45 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
10% Owner |
– – • |
2017-03-23 |
4 |
B |
$1.60 |
$7,528 |
D/D |
4,705 |
4,791,387 |
2.37 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
10% Owner |
– – • |
2017-03-22 |
4 |
B |
$1.79 |
$1,790,000 |
D/D |
1,000,000 |
4,786,682 |
2.45 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
10% Owner |
– – • |
2017-03-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,786,682 |
|
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
10% Owner |
– – • |
2017-03-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
220,000 |
|
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2017-01-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(12,747) |
0 |
0 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2017-01-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(930,762) |
0 |
0 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2015-12-03 |
4 |
S |
$15.31 |
$1,071,546 |
D/D |
(70,000) |
930,762 |
0 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2015-03-12 |
4 |
S |
$14.65 |
$577,078 |
D/D |
(39,391) |
1,000,762 |
0 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2014-12-11 |
4 |
S |
$14.72 |
$641,574 |
D/D |
(43,600) |
1,040,153 |
0 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2014-03-07 |
4 |
S |
$15.51 |
$1,860,720 |
D/D |
(120,000) |
1,083,753 |
0 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2014-02-25 |
4 |
S |
$15.25 |
$915,000 |
D/D |
(60,000) |
1,203,753 |
0 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2014-02-20 |
4 |
S |
$15.63 |
$1,875,060 |
D/D |
(120,000) |
1,263,753 |
0 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2013-12-12 |
4 |
S |
$14.76 |
$221,421 |
D/D |
(15,000) |
1,383,753 |
0 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2011-06-10 |
4 |
B |
$8.65 |
$173,000 |
D/D |
20,000 |
1,398,753 |
2.39 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2010-08-18 |
4 |
B |
$5.14 |
$205,752 |
D/D |
40,000 |
1,378,753 |
2.39 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2009-03-13 |
4 |
B |
$0.89 |
$27,347 |
D/D |
30,900 |
1,050,173 |
2.39 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2009-03-06 |
4 |
B |
$0.61 |
$213,500 |
D/D |
350,000 |
1,019,273 |
2.39 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2008-11-20 |
4 |
B |
$4.64 |
$46,400 |
I/I |
10,000 |
10,000 |
2.1 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2008-11-13 |
4 |
B |
$5.79 |
$52,110 |
D/D |
9,000 |
669,273 |
2.39 |
- |
|
| ACAS |
American Capital Ltd |
Director |
– • – |
2008-09-05 |
4 |
B |
$20.86 |
$997,928 |
D/D |
47,840 |
660,273 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
